Every year, more and more Americans are diagnosed with type 2 diabetes mellitus and, according to a recent study, in the near future that number could reach close to 40% of the population.
With so many factors to consider in the treatment of multiple sclerosis, the panelists identify several “unmet needs” of patients with multiple sclerosis and discuss several options for managing them.
A new drug was given tentative approval by the US Food and Drug Administration to help patients with both type 1 and type 2 diabetes.
Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.
The Ebola epidemic is spreading in West Africa, with little hope for treatment, and an experimental therapy is unlikely to be provided to African patients, according to two commentaries published online Aug. 19 in the Annals of Internal Medicine.
Some subpopulations of patients with diabetes carry a higher burden of diabetic macular edema, according to a study published online Aug. 14 in JAMA Ophthalmology.
Cancer screening is common among those with limited life expectancy, and more frequent colorectal cancer screening than recommended does not provide benefit, according to two studies published online Aug. 18 in JAMA Internal Medicine.